Drugs that contain Gemcitabine Hydrochloride
1. Gemzar patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5464826 | LILLY | Method of treating tumors in mammals with 2',2'-difluoronucleosides |
Nov, 2012
(11 years ago) | |
|
US5464826 (Pediatric) | LILLY | Method of treating tumors in mammals with 2',2'-difluoronucleosides |
May, 2013
(10 years ago) | |
Market Authorisation Date: 15 May, 1996
Treatment: Method of treating susceptible neoplasms in mammals
Dosage: INJECTABLE;INJECTION
How can I launch a generic of GEMZAR before it's drug patent expiration?
More Information on Dosage
GEMZAR family patents
2. Infugem patents expiration
INFUGEM's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9241948 | SUN PHARM | Ready to be infused gemcetabine solution |
Jul, 2033
(9 years from now) | |
Market Authorisation Date: 16 July, 2018
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
INFUGEM family patents